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Background and PurposezzThere is recent evidence of various types of morphological chang-
es in the hippocampus of a rodent model of medial temporal lobe epilepsy (mTLE). However, 
little is known about such changes in humans. We examined the histological changes [i.e., neuro-
nal loss, cell genesis, and granule cell dispersion (GCD)] in surgical hippocampal specimens tak-
en from patients with mTLE.
MethodszzNissl staining, and nestin and Prox1 immunohistochemistry were performed on human 
hippocampal specimens obtained from patients with medically intractable mTLE, thus allowing 
the analysis of neuronal loss, cell genesis, and GCD, respectively. We also assessed the correlations 
between clinical parameters and the histopathologic findings.
ResultszzThe degree of cell genesis in the granule cell layer was significantly correlated with the 
severity of GCD, history of childhood febrile seizures, and frequent generalized seizures. Cell gen-
esis was not correlated with cell death, age at seizure onset, duration of epilepsy, or the mean fre-
quency of all seizures.
ConclusionszzOur results indicate that cell genesis in the dentate gyrus of patients with mTLE is 
associated with GCD and is influenced by the presence of febrile seizures during childhood and 
the frequency of episodes of generalized seizures.
  J Clin Neurol 2010;6:73-80
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Introduction
Hippocampal sclerosis (HS) is the most common lesional ab-
normality identified in patients with temporal lobe epilepsy 
(TLE).
1,2 HS is characterized by severe loss of the principal 
neurons in areas CA1 and CA3 of the hippocampus, and is fre-
quently associated with widening of the granule cell layer of 
the dentate gyrus, termed granule cell dispersion (GCD), which 
is observed in about 40-50% of surgical temporal lobe speci-
mens.
3-6 Despite their importance in TLE, the pathogenic mech-
anisms underlying this distinctive hippocampal pathology have 
not yet been identified. Whether HS represents the cause or the 
consequence of chronic seizure activity and pharmacoresis-
tant TLE also remains to be established.
7
The clinical significance of the morphological changes ob-
served in the hippocampi of patients with medial TLE (mTLE) 
is ambiguous, in spite of the many relevant studies that have 
been conducted over the last 50 years. Although there have been 
many suggestions of a positive correlation between the severi-
ty of hippocampal neuronal loss and clinical parameters that 
indicate a greater seizure burden [e.g., younger age of onset, 
longer duration of epilepsy, greater number of generalized sei-Neuropathologic Features of TLE
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zures, and presence of status epilepticus (SE) and initial precipi-
tating injuries (IPI)], there is currently no reliable evidence of 
such a relationship.
8-13
In addition to the relationship between clinical and patho-
logical parameters, there is no established evidence of a rela-
tionship between the pathological parameters themselves. For 
example, the development of GCD in the hippocampus is th-
ought to be affected by excessive neurogenesis as a result of 
seizures in rodent models of TLE.
14 However, there are insuffi-
cient and conflicting data about the relationship between GCD 
and cell proliferation in the human hippocampus.
15,16
In the study presented here, we examined the histological ch-
anges associated with TLE in terms of neuronal loss, cell gen-
esis, and GCD in surgical hippocampal specimens taken from 
patients with pharmacoresistant mTLE and HS. We also exam-
ined both the clinicopathologic relationship and the interrela-
tionship between these pathologic changes to better underst-
and the clinical significance and pathologic mechanisms 
underlying the histological changes in mTLE.
Methods
Subjects
Cases were selected from the pathology archives at the De-
partments of Neurology and Neurosurgery, Seoul National 
University Hospital, Seoul, Korea. The research was approved 
by the Hospital Committee on Human Ethics. The hippocam-
pal specimens were obtained from 26 patients who had under-
gone temporal lobectomy between 2000 and 2006, including 
hippocampal resection, for the treatment of medically intracta-
ble mTLE with HS. Medically intractable patients were defined 
as those whose seizures were poorly controlled with two or 
more anticonvulsant drugs prescribed by an epileptologist, 
including at least one of the following: phenytoin, carbamaze-
pine, and valproic acid.
17 All patients went through a compre-
hensive clinical, electrophysiological, neuropsychological, and 
imaging evaluation before the epilepsy surgery.
Clinical data collection
Clinical data were obtained for each patient by reviewing all 
records available in the electronic medical records at the hos-
pital. These data included the patient’s sex, age at epilepsy on-
set, age at surgery, duration of epilepsy, average frequency of 
preoperative complex partial and generalized seizures, histo-
ry of childhood febrile seizure (FS) or other significant IPI,
18 
age at FS or IPI, history of SE, and surgical outcomes.
Tissue preparation and immunohistochemistry
The brain specimens were cryopreserved as tissue blocks for 
cryostat sectioning at a thickness of 7 μm. Coronal sections were 
taken from the right or left hippocampus, and every seventh se-
ction of the hippocampus (6 sections per specimen) was sub-
jected to semiquantitative immunohistochemical analysis. All 
hippocampal specimens were processed identically to mini-
mize the effect of differential shrinkage on neuronal density 
measurements. Histological evaluations were performed as de-
scribed previously.
19-21 Paraffin-embedded sections from se-
lected HS patients were dewaxed, rehydrated through graded 
alcohols, and taken to water. Sections were microwaved for 
15 minutes in 0.05 M EDTA (pH 7.5) and then allowed to cool 
for 20 minutes.
Sections were stained using the Nissl method and labeled 
with antinestin (1 : 100, Chemicon, Temecula, CA, USA) and 
anti-Prox1 antibodies (1 : 60, Abcam, Cambridge, UK). Nestin, 
which is a protein of the intermediate filament family, is typi-
cal of undifferentiated neural stem and progenitor cells.
22 
Prox1 is expressed in postmitotic dentate granule cells, is spe-
cific for this cell type in the adult rat dentate gyrus,
23-25 and is 
used to identify ectopic granule cells following pilocarpine-
induced SE.
26,27 Biotinylated goat antimouse IgG (ABC, Sig-
ma, Poole, UK) was used as the secondary antibody. The bi-
otin signal was detected using 3,3’-diaminobenzidine (brown) 
and Vector VIP (purple). Prox1 expression was detected by 
nickel-enhanced diaminobenzidine peroxidase immunohisto-
chemistry, as described previously.
26,27 We also examined the 
extrahippocampal pathological findings. The surgically ex-
cised temporal lobe specimens were fixed in formaldehyde 
after extirpation and then stained with hematoxylin and eosin.
Grading system
Histological analysis was performed in the predefined areas 
of consecutive coronal blocks of 6 serial sections. The cells of 
interest were evaluated in the CA3 area for hippocampal neu-
ronal damage, the hilus for nestin immunoreactivities, and the 
granule cell layer for GCD. The region of interest was set to 
include the proximal, middle, and distal subfields of area CA3 
stratum pyramidale (magnification ×400), the whole hilar 
area (magnification ×400), and the superior and inferior por-
tions of the granule cell layer (magnification ×600). It is not 
possible to perform unbiased stereology in human surgical 
tissue samples where the entire region of interest is not pres-
ent,
28 and so we adapted the semiquantitative scoring system of 
histopathological results as follows. Neuronal loss was mea-
sured on a scale of 0-3, where grades 0, 1, 2, and 3 correspond-
ed to 0%, 20%, 20-50%, and >50% of the neurons lost in the 
particular subfield, respectively. The mean and SD values of 
the score were calculated from the scored sections.
28 Cell gen-
esis was measured on a scale of 1-4, where grade 1 was “few 
or no nestin-positive cells present (<3 cells/high-power field, 
HPF)”, grade 2 was “a few nestin-positive cells present (3-10 Bae EK et al.
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cells/HPF)”, grade 3 was “a moderate number of nestin-positive 
cells present (10-100 cells/HPF)”, and grade 4 was “a high num-
ber of nestin-positive cells present (>100 cells/HPF).” The mean 
and SD values were calculated from the scored sections for 
each area separately (modified from Pirttilä et al.
28). GCD was 
also measured on a scale of 1-4, where grade 1 describes epi-
leptic qualities and a nondispersed appearance, grade 2 de-
scribes granule cell bodies dispersed into the molecular layer 
forming an irregular outer border, grade 3 describes double-
layer granule cell bodies organized into two layers, and grade 
4 describes predominantly granule cell death (Fig. 1).
3,28
Statistical analysis
The data are presented as mean±SD values. The Pearson cor-
relation coefficient was determined to assess the associations 
between variables. Two groups were compared by chi-square 
analysis with arbitrary dichotomization, using SPSS for win-
dows (version 15.0; SPSS Inc, Chicago, IL, USA). A value of 
p<0.05 was considered significant. 
Results
Clinical characteristics of the patients
The clinical characteristics of the 26 patients, who comprised 
15 men and 11 women who were aged 32.07±9.29 years (ran-
ge, 16-43 years) at the time of surgery, are listed in Table 1. 
The age at the onset of epilepsy was 11.11±6.98 years (range, 
1-27 years), and the duration of epilepsy at the time of collec-
tion was 17.76±10.58 years (range, 1-42 years). All patients 
had complex partial seizures, and the frequency of seizures 
per month was 4.25±5.98 (range, 0.5-30). In 16 patients 
(61.5%), secondary generalization frequently occurred more 
than once per month. A history of childhood FS was reported 
in 13 patients (50%), and 7 patients reported other relevant ca-
usative childhood events (IPI), for example head trauma, men-
ingitis, encephalitis, and Reye syndrome. No patient reported a 
history of SE. Most of the patients (80.7%) became seizure-
free after their epilepsy surgery.
Pathological findings
The pathological grading scores of Nissl (for neuronal loss), 
nestin (for cell genesis), and Prox1 (for GCD) are listed in Ta-
ble 2, based on the grading system presented in Fig. 1. Most pa-
tients showed a moderate-to-severe amount of neuronal loss: gra-
de 3 in 12 patients (46.2%), grade 2 in 10 patients (38.5%), and 
grade 1 in 1 patient (3.8%). Most patients showed a mild-to-
moderate amount of cell genesis: grade 1 in 8 patients (30.8%), 
grade 2 in 6 patients (23.1%), grade 3 in 11 patients (42.3%), 
Fig. 1. Histopathological results of the 
semiquantitative scoring system. Nissl 
staining (for neuronal loss) shows (A) gra-
de 1, 20% of neurons lost, (B) grade 2, 
20-50% of neurons lost, and (C) grade 3 
>50% of neurons lost. Nestin immunos-
taining (for cell genesis) shows (D) 
grade 1, few positive cells present (<3 
cells/HPF), (E) grade 2, a few positive ce-
lls present (3-10 cells/HPF), (F) grade 3, 
a moderate number of positive cells pre-
sent (10-100 cells/HPF), and (G) grade 
4, a high number of positive cells pres-
ent (>100 cells/HPF). Prox1 immunos-
taining (for GCD) shows (H) grade 2, gra-
nule cell bodies dispersed into the mo-
lecular layer forming an irregular outer 
border, (I) grade 3, double-layer granule 
cell bodies organized in two layers, and 
(J) grade 4, granule cell death prevails. Sca-
le bar=100 μm. GCD: granule cell disper-
sion.Neuropathologic Features of TLE
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and grade 4 in 1 patient (3.8%). All patients exhibited some de-
gree of GCD: grade 2 in 13 patients (50%), grade 3 in 7 patients 
(26.9%), and grade 4 in 6 patients (23.1%). With regard to the 
extrahippocampal pathological findings, only one patient ex-
hibited apparent cortical dysplasia on magnetic resonance 
imaging (MRI) and macroscopic examination. However, 11 pa-
tients (42.3%) exhibited MRI-negative microscopic dyspla-
sia in the resected temporal lobe specimens on histological ex-
amination.
Association between clinical and pathological va-
riables
There were significant correlations between cell genesis and 
GCD (r=0.43, p=0.03) and between neuronal loss and GCD 
(r=0.73, p<0.01). Clinical variables, including age at onset, age 
at surgery, duration of epilepsy, and mean frequency of preop-
erative seizures, were not correlated with the pathological vari-
ables, including neuronal loss, cell genesis, and GCD (Table 3). 
We dichotomized the results of nestin immunoreactivity into a 
mild degree of cell genesis (grades 1 and 2) and a moderate-to-
severe degree (grades 3 and 4). Moderate-to-severe cell gene-
sis occurred more frequently in patients with a history of FS 
(p=0.03)(Fig. 2) and in those with frequent generalized seizures 
(p=0.026, both by chi-square test)(Fig. 2). Neuronal loss and 
GCD were not significantly correlated with FS or with the fre-
quency of generalized seizures. The presence of temporal micro-
scopic dysplasia was not significantly correlated with the oth-
er pathological findings, including neuronal loss, cell genesis, 
or GCD, or with any clinical variable including the history of FS 
and frequent generalized seizures.
 
Discussion
We investigated the histological changes (neuronal loss, cell 
genesis, and GCD) in the hippocampus from mTLE patients. 
Cell genesis, measured as the number of nestin-positive cells 
in the granule cell layer, was significantly correlated with the 
severity of GCD, history of childhood FS, and frequent gen-
Table 1. Clinical parameters of medial temporal lobe epilepsy patients
Patient 
no.
Sex 
Onset age 
(years)
Surgery age 
(years)
Epilepsy duration 
(years)
Seizure frequency 
(times/month)
Secondary 
generalization 
FS IPI
Age at 
IPI (years)
01 F  01 43 42 8 F  – Head trauma  01
02 M  04 23 19 3.5 R  + – 00
03 F  04 37 33 4 F  – – 00
04 F  16 28 12 8 F  + – 00
05 M  14 27 13 0.5 R  + Head trauma  12
06 F  11 19 08 5 R  – Reye syndrome 03
07 F  01 18 17 1 F  + – 01
08 M  13 21 08 0.5 F  + Meningitis 03
09 M  27 39 12 2.5 F  – Encephalitis 06
10 M  06 20 14 30 F  + – 00
11 M  16 51 35 1.5 F  – – 00
12 M  11 37 26 10 R  – – 00
13 F  12 16 04 1 F   + – 00
14 M 15 27 12 1 F  + – 00
15 M 20 31 11 1 F  – Encephalitis  10
16 M 03 24 21 2 F  + – 03
17 F 10 42 32 10 R  – – 00
18 F 08 33 25 2 R  + – 00
19 F 25 25 01 2 F  + – 00
20 F 06 20 14 0.5 R  – – 00
21 M 02 29 27 3 F  – – 02
22 M 16 22 06 ? R  – – 00
23 M 16 21 05 1 F  + – 00
24 M 10 36 26 3.5 F  – – 00
25 F 16 33 17 5 R  + – 00
26 M 06 28 22 1 R  – Encephalitis  05
Not all clinical data were available for every patient. For secondary generalization, F (frequent) means more than once per month and 
R (rare) means less than once per month.
M: male, F: female, FS: febrile seizures, IPI: initial precipitating injuries.Bae EK et al.
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eralized seizures. However, cell genesis was not associated with 
the extent of neuronal loss, age of seizure onset, duration of epi-
lepsy, or the mean frequency of seizures in the preoperative 
period. In addition, the presence of microscopic cortical dys-
plasia in the surgical temporal lobe specimens was not corre-
lated with other pathologic parameters including the degree 
of neuronal loss, cell genesis, and GCD. These results suggest 
that newly generated granule cells lead to GCD and are likely 
to be influenced by FS in childhood and by frequent episodes 
of generalized seizures.
Granule cell neurons are generated throughout life from a 
population of continuously dividing progenitor cells that reside 
in the subgranular zone of the rodent dentate gyrus.
29 This also 
seems to occur in humans, because new neurons, as identified 
by bromodeoxyuridine staining, are generated from dividing 
progenitor cells in the dentate gyrus of the adult human brain.
30 
Prolonged seizure activity markedly increases neurogenesis in 
the dentate gyrus of adult rats. Pulse-chase bromodeoxyuridine 
labeling and immunohistochemistry for immature neuronal 
markers show that many newly generated neurons migrate in 
chains from the dentate subgranular zone to ectopic locations 
in the hilus and molecular layer after pilocarpine-induced SE.
26 
Thus, one hypothesis is that GCD in humans with TLE results 
from enhanced neurogenesis induced by prolonged seizures. 
Although our results support this hypothesis, some recent studi-
es have shown contrary results. For example, in a rodent model 
of epilepsy after kainate injection and in the hippocampi from 
patients with TLE, GCD does not result from increased neuro-
genesis, but rather from abnormal migration of mature gran-
ule cells along a radial glial scaffold, most likely caused by lo-
cal reelin deficiency.
15,31 Nestin, which is an indicator of cell 
genesis, is expressed in the neuroglial cells in addition to undif-
ferentiated precursors of neurons.
22 Therefore, nestin positivity 
cannot be attributed entirely to neurogenesis, and this may ex-
plain some of the differences between our data and those of 
previous studies.
We demonstrated increased cell genesis in patients with fre-
quent generalized seizures. Likewise, seizure-induced neuro-
Table 2. The pathological grading scores of Nissl staining, and nes-
tin and Prox1 immunohistochemistry, and the presence of cortical 
dysplasia in human temporal lobe surgical specimens 
Patient
no.
Cell 
genesis
(Nestin)
Neuronal 
loss (Nissl)
Granule cell 
dispersion 
(Prox1)
Cortical dysplasia 
in the temporal 
lobe surgical 
specimen
01 1 1 2 +
02 2 3 3 +
03 2 2 2 +
04 1 1 2 –
05 3 2 2 –
06 1 3 3 –
07 3 2 2 –
08 2 3 3 +
09 3 3 4 +
10 3 3 2 +
11 3 3 4 +
12 1 3 4 +
13 3 2 3 +
14 3 2 3 –
15 3 1 2 –
16 3 3 4 –
17 1 2 2 +
18 2 1 2 –
19 2 2 2 –
20 1 2 2 –
21 3 3 3 –
22 1 2 2 –
23 3 3 4 +
24 4 3 4 –
25 2 3 3 –
26 1 2 2 –
Table 3. Pearson correlation coefficients between clinical vari-
ables and pathological results
Cell genesis 
(Nestin)
Neuronal 
loss (Nissl)
Granule cell 
dispersion (Prox1)
Surgery age
Correlation -0.06 -0.11 0.16
p 0.76 0.59 0.45
Onset age
Correlation 0.12 0.01 0.19
p 0.56 0.97 0.35
Epilepsy duration
Correlation -0.1 -0.07 0.04
p 0.61 0.72 0.85
Seizure frequency 
(Per month)
Correlation -0.11 0.13 -0.17
p 0.6 0.52 0.41
Cell genesis 
(Nestin)
Correlation – 0.32 0.43
p – 0.12 0.03*
Neuronal loss
(Nissl)
Correlation 0.32 – 0.73
p 0.12 – <0.01*
Granule cell 
dispersion (Prox 1)
Correlation 0.43 0.73 –
p 0.03* <0.01* –
*Denotes significant correlation.Neuropathologic Features of TLE
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genesis in the dentate gyrus has been proven in various ani-
mal models, such as, pilocarpine-induced SE,
20,21,32 kainic 
acid injection,
33 and amygdala kindling.
34 Seizure-induced neu-
rogenesis has also been described in adults
16 and in children 
with mTLE.
35,36 Although the role of seizure-induced neurogene-
sis in the pathophysiology of TLE is uncertain, it is possible 
that newly generated cells contribute to the formation of GCD 
and ectopic granule cells in the hilus. Seizure-induced cell pro-
liferation and the likelihood of developing spontaneous recu-
rrent seizures following pilocarpine-induced SE are reduced 
by the antimitotic agent cytosine-b-D-arabinofuranoside in 
adult rodent models, which suggests that hippocampal cell pro-
liferation plays a proepileptic rather than a compensatory role.
20
Experimentally prolonged FS results in late-onset limbic 
(temporal lobe) epilepsy,
37 but the epileptogenic potential of 
prolonged FS in humans remains unclear. Although retrospec-
tive analysis has implicated early-life FS as a risk factor for the 
development of TLE in humans,
38 whether early-life FS actu-
ally causes TLE or is simply indicative of another, perhaps gene-
tically determined vulnerability that eventually results in TLE, 
cannot be determined in correlative clinical studies.
37 Moreover, 
the epileptogenic mechanisms underlying FS remain unknown, 
but might involve enduring changes at the molecular and func-
tional levels, such as alterations in neurotransmitter receptors 
or voltage-gated ion channels, and might not involve neuronal 
loss.
39 Although the effects of FS on cell proliferation in the den-
tate gyrus have been described in animal models,
40,41 there is 
little evidence of this in humans. We found a positive correla-
tion between early-life FS and ongoing cell proliferation in adult 
human hippocampi taken from TLE patients, but further par-
allel human and animal studies are needed to demonstrate the 
role of altered cell proliferation after FS and other epileptogen-
ic mechanisms of FS.
We found a positive correlation between the severity of HS 
(i.e., neuronal loss) and the presence of GCD, which is in ac-
cordance with the results of recent studies
5,6,13 and with the ori-
ginal work by Houser.
3 Considering that the presence of GCD 
was not correlated with clinical factors such as duration of epi-
lepsy or frequency of seizures, GCD might be more closely 
linked to the pathological process of HS rather than being a 
manifestation of severe temporal lobe seizures.
6 We also found 
no correlation between clinical variables relating to seizure bur-
den and the severity of HS. This is a conflicting area, and most 
pathological or longitudinal MRI studies have suggested a 
correlation between the severity of hippocampal neuronal loss 
and the duration of epilepsy.
13 However, few studies have thor-
oughly determined of the burden of seizures,
13 and one limita-
tion to our study is that we did not know the exact total number 
of generalized and partial seizures. Despite this limitation, we 
found no evidence that HS occurs as a consequence of recur-
rent seizures in patients with TLE.
Microscopic cortical dysplasia or microdysgenesis mani-
fests as minor abnormalities on histological examination, even 
when the MRI or macroscopic examination reveals no abnor-
malities.
42 Microscopic cortical dysplasia may appear in 20-
45% of surgical specimens from mTLE patients with HS.
43-45 
We found microscopic cortical dysplasia in 11 patients (42.3%), 
a rate similar to that of previous reports, suggesting that it is a 
relatively commonly associated finding in HS. It has been su-
ggested that this represents a preexisting susceptibility factor 
that renders the affected brain vulnerable to the development 
of mTLE after IPI or FS, but the reciprocal relationship re-
mains unknown.
43 Recent data show that microscopic cortical 
dysplasia is not related to clinical parameters such as IPI or FS, 
or to the histological characteristics of HS;43-45 our results are 
consistent with these previous findings. Hence, the role of mi-
croscopic cortical dysplasia is currently obscure, and future 
studies are needed to reveal the complexities.
The semiquantitative scoring system that we applied has 
Fig. 2. The distribution of (A) patients with or without a history of 
FS and (B) with frequent or rare generalized seizures, relative to 
the degree of nestin positivity (cell genesis). A mild degree of cell 
genesis was classified as the pathological grading score of nestin 
of 1 or 2, and a moderate-to-severe degree of cell genesis was 
classified as grade 3 or 4. Cell genesis was significantly higher in 
patients with a history of FS (p=0.030) and with frequent general-
ized seizures (p=0.026). FS: febrile seizures.
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some limitations. We were unable to quantify real cell counts 
for neuronal loss and cell genesis, or to measure the real thick-
ness of granule cell layer for GCD, because the tissue sections 
of the surgical specimens did not precisely correspond. Our re-
sults may thus be inconclusive; nevertheless, we think that our 
results might be suggestive of the neuropathologic features of 
human specimens.
In conclusion, our study showed that increased cell genesis 
is correlated with the severity of GCD in the human hippocam-
pal dentate gyrus of medically intractable mTLE patients, sup-
porting the view that newly generated granule cells might lead 
to GCD. The degree of cell genesis was also related to the his-
tory of childhood FS and frequent generalized seizures, but 
was not significantly associated with the degree of neuronal 
loss or other clinical variables, such as the age at onset, dura-
tion of epilepsy, or the mean frequency of all seizures.
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